Trials & Research Projects

We fund ideas that are ready for clinical studies and provide seed funding to help research projects move forward.

Cancer Trials and Projects

Find a Complete list of Emory's Cancer Clinical Trials at the Winship Cancer Institute »

Morningside Center: COVID-19 Trials and Projects

The Morningside Center has been involved in various projects related to COVID-19 and repurposed drugs. Some of these initiatives include:

Fluvoxamine Study

A widely quoted review on fluvoxamine in COVID-19 has been written by Vidula and Vikas Sukhatme.

Read Fluvoxamine review
researcher analyzing medicine

FDA-funded Long COVID Study

The Morningside Center has been working with the Federal Drug Administration to develop a randomized adaptive design study in COVID-19 outpatient and inpatient settings and provided guidance to the FDA on using repurposed drugs to treat "long COVID," or post-acute sequelae of COVID-19 (PASC). The Morningside Center was able to receive a grant from the FDA that will enable data extraction on COVID-19 patients in the Emory Healthcare system.

person wearing mask with head in their hands

DoD Health Monitoring and Long COVID Projects

Morningside team members are working with the Department of Defense on a suite of assays that monitor human health. They have also provided the DoD guidance on post-acute sequelae of COVID-19 (PASC), with the potential for future grants in this area.

doctor visual analyzing liquid in a jar



Innovating with Existing Drugs and Nutraceuticals Conference

November 14-15, 2019

Emory Conference Center Hotel, Atlanta, GA

Watch Dr. Vikas Sukhatme’s opening remarks
conference lecture